A citation-based method for searching scientific literature

Talmadge E King, Annie Pardo, Moisés Selman. Lancet 2011
Times Cited: 1197



Yi-Min Liu, Kunal Nepali, Jing-Ping Liou. J Med Chem 2017
Times Cited: 75




List of shared articles



Times cited

Structural and PK-guided identification of indole-based non-acidic autotaxin (ATX) inhibitors exhibiting high in vivo anti-fibrosis efficacy in rodent model.
Hongrui Lei, Zhi Cao, Huinan Wu, Tong Li, Xinyu Wang, Yuxiang Chen, Enlong Ma, Lixin Sun, Xin Zhai. Eur J Med Chem 2022
1

Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis.
Hongbo Ma, Shengming Liu, Shanrui Li, Yong Xia. Front Pharmacol 2022
2

Novel imidazo[1,2-a]pyridine derivatives as potent ATX allosteric inhibitors: Design, synthesis and promising in vivo anti-fibrotic efficacy in mice lung model.
Hongrui Lei, Zhen Li, Tong Li, Huinan Wu, Jing Yang, Xinlian Yang, Yu Yang, Nan Jiang, Xin Zhai. Bioorg Chem 2022
0

Hybrid imidazo[1,2-a]pyridine analogs as potent ATX inhibitors with concrete in vivo antifibrosis effect.
Tong Li, Hongrui Lei, Juanjuan Yang, Zhi Cao, Yu Yang, Zimeng Liu, Ruonan Sun, Xinlian Yang, Xin Zhai. Arch Pharm (Weinheim) 2022
0

Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis.
Jincheng Wang, Kaili Hu, Xuanyan Cai, Bo Yang, Qiaojun He, Jiajia Wang, Qinjie Weng. Acta Pharm Sin B 2022
10